Methods of using cannabinoids for inhibiting induction of virulence in enteric pathogens
OwnerJay Mellies, Vanessa Sperandioinventors
Life of this patent
Estimating the term…
Abstract
Methods of treating a subject having a gram negative bacterial infection by administering a cannabinoid such as 2-AG,CBD, the MgI inhibitor JZL184, or arachidonic acid to the subject are provided. Methods of prophylactically treating a subject at risk of developing a gram negative bacterial infection and for reducing the bacterial virulence in an infected subject are also provided.
Claims30
1-25. (canceled)
A method of reducing bacterial virulence in a subject with a gram negative bacterial infection, comprising:
- administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising a cannabinoid and a pharmaceutically acceptable carrier.
(canceled)
(canceled)
36-38. (canceled)
(canceled)
44-46. (canceled)
A method for reducing bacterial virulence in a subject having an antibiotic-resistant gram negative bacterial infection, comprising:
- administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising a cannabinoid and a pharmaceutically acceptable carrier to reduce a pathological effect or symptom of the gram negative bacterial infection.
50-53. (canceled)
(canceled)
(canceled)
61-62. (canceled)
Dependencies are inferred from the claim text.